|
|
||||||||
|
|
|||||||||
|
|
Oncology-Basic Science: Therapy, Metrics & InterventionTechnical Issues, Reproducibility and Quantification |
1 VU University Medical Center, Amsterdam, Netherlands
424
Objectives: To evaluate the test-retest variability of various (semi-) quantitative outcome measures of [18F]FLT studies.
Methods: 9 patients (pts) with non-small-cell lung cancer (NSCLC) and 6 with head and neck cancer (HNC) were scanned twice (within 7 days) using an ECAT EXACT HR+ scanner. Acquisition consisted of a 10 min transmission scan, followed by a 60 min 2D dynamic emission scan, starting simultaneously with administration of 370 MBq [18F]FLT. Volumes of interest (41% threshold) and SUVmax were defined on OSEM reconstructed images summed over 45-60 min p.i. and transferred to FBP reconstructed dynamic images for generating time-activity curves. An input function was obtained by continuous arterial blood sampling for HNC pts and image derived (aorta and/or LV) for NSCLC pts. Corrections for plasma/whole blood ratio and metabolites were based on 6 manual samples. Reproducibility of full kinetic (NLR, Patlak) and simplified (SUV) measures was explored using intraclass correlation coefficients (ICC) and Bland-Altman plots.
Results: A total of 24 lesions in 15 pts was analysed. Except for NLR k3, all measures showed excellent reproducibility.
|
Bland-Altman analysis did not show dependency on level of FLT uptake and PET estimated tumor volume.
Conclusions: These data suggest that with serial imaging of pts, a change of >14% in SUV41% or >22% in SUVmax and Patlak Ki (>2 SD) is likely to represent a biological effect. NLR k3, selectively reflecting TK1 activity, showed poor reproducibility.
| ||||||||||||||||||||||||||||||||||||||